Common GLP-1 Agonists Here is a list of some of the most common GLP-1 medications approved by the FDA: For Type 2 Diabetes: Adlyxin (lixisenatide) Ozempic (semaglutide) Rybelsus (semaglutide, oral tablet) Trulicity (dulaglutide) Victoza (liraglutide) Combination medications like Soliqua Vial (lixisenatide and insulin glargine) For Obesity: Saxenda (liraglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Numerous other states are considering adding these medications because of the potential benefits of reducing obesity and the health complications it may prompt
Weight Watchers Med+ members prescribed a GLP-1 who regularly engaged with the GLP-1 Success Program lost 61.3% more body weight at one month , and 29.1% more at 12 months , on average, compared to those who used GLP-1s without behavioral support.* With more than 60 years of weight-health expertise, Weight Watchers is now bringing its deep library of trusted nutrition content into ChatGPT helping you get personalized meal ideas, GLP-1-friendly recipes, and practical food guidance right when questions come up
Injectable GLP-1 agonists and meals For subcutaneous injectable formulations, including semaglutide, tirzepatide, dulaglutide, and liraglutide, there is no requirement to time your injection around meals
I couldnt sustain my weight coming out of a car and I fell on to the road
The appetite suppression profile is similar because both compounds activate GLP-1 receptors, but many users report that retatrutide appetite suppression feels qualitatively different
The STEP trial extension data showed that participants regained approximately 40 percent of lost weight within 28 weeks of stopping semaglutide
